Name: UMIN ID:
Unique ID issued by UMIN | UMIN000008613 |
---|---|
Receipt number | R000010123 |
Scientific Title | Phase I trial of Bevacizumab and S-1 chemotherapy for patients with previously treated advanced non-small cell lung cancer |
Date of disclosure of the study information | 2012/08/06 |
Last modified on | 2021/02/10 11:47:07 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/08/04 10:33:25 | ||
2 | Update | 2014/10/04 20:42:44 | Email Last name of contact person Last name of contact person Address Address TEL Name of person sending information Name of person sending information |
|
3 | Update | 2016/08/08 23:00:19 | Name of primary person or sponsor Institute Organization |
|
4 | Update | 2018/06/14 12:54:11 | Last name of contact person Last name of contact person Name of person sending information Name of person sending information Name of primary person or sponsor Organization Email1 |
|
5 | Update | 2021/02/10 10:46:30 | UMIN ID1 |
|
6 | Update | 2021/02/10 11:47:07 | Recruitment status Date of IRB Last follow-up date Date of closure to data entry |